Technical Analysis for WVE - WAVE Life Sciences Ltd.

Grade Last Price % Change Price Change
grade C 24.84 0.16% 0.04
WVE closed up 0.16 percent on Friday, September 20, 2019, on 1.21 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical WVE trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
New Uptrend Bullish 0.16%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.16%
Upper Bollinger Band Walk Strength 0.16%
Calm After Storm Range Contraction -3.16%

Older signals for WVE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company was founded in 2012 and is based in Singapore.
Rare Diseases Medical Genetics Inflammatory Bowel Disease Muscular Dystrophy Huntington's Disease Duchenne Muscular Dystrophy Genetic Genealogy Genodermatoses Cytoskeleton Dystrophin Ibd SNP
Is WVE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 56.0
52 Week Low 18.16
Average Volume 229,732
200-Day Moving Average 31.9133
50-Day Moving Average 22.4674
20-Day Moving Average 23.264
10-Day Moving Average 24.681
Average True Range 1.5528
ADX 27.32
+DI 31.0934
-DI 12.7272
Chandelier Exit (Long, 3 ATRs ) 23.4416
Chandelier Exit (Short, 3 ATRs ) 25.2684
Upper Bollinger Band 27.0881
Lower Bollinger Band 19.4399
Percent B (%b) 0.71
BandWidth 32.875688
MACD Line 0.9331
MACD Signal Line 0.6495
MACD Histogram 0.2836
Fundamentals Value
Market Cap 689.56 Million
Num Shares 27.8 Million
EPS -3.35
Price-to-Earnings (P/E) Ratio -7.41
Price-to-Sales 250.07
Price-to-Book 3.20
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.67
Resistance 3 (R3) 25.60 25.25 25.53
Resistance 2 (R2) 25.25 25.04 25.29 25.48
Resistance 1 (R1) 25.05 24.91 25.15 25.12 25.44
Pivot Point 24.70 24.70 24.76 24.74 24.70
Support 1 (S1) 24.50 24.49 24.60 24.57 24.24
Support 2 (S2) 24.15 24.36 24.19 24.20
Support 3 (S3) 23.95 24.15 24.15
Support 4 (S4) 24.02